Blocking of human T lymphocyte activation by channel antagonists
- PMID: 2477169
- DOI: 10.1002/cbf.290070311
Blocking of human T lymphocyte activation by channel antagonists
Abstract
It has been established that early events in lymphocyte activation involve a rise in intracellular Ca++ as well as changes in the flux of other ions. Although a Ca++ channel has been postulated to participate in the early Ca++ rise, its presence in lymphocytes remains controversial. Also although yet undetected, electrophysiological data suggest the presence of a Ca++ activated K+ channel on human peripheral blood lymphocytes (HPBL). Here we report on the effect of specific channel blockers as an approach to the identification of these channels on HPBL. At 40 nM nifedipine, an inhibitor of voltage-gated Ca++ channels, fully inhibits the PHA-promoted activation of HPBL. This effect is concentration dependent with a half maximum effect at approximately 10 nM and is demonstrable whether the drug is added at the same time as or up to 18 h after the addition of the mitogen. This inhibition of activation is not seen if the lymphocytes are activated using IL-2 instead of PHA. Charybdotoxin a toxin which blocks a Ca++ activated K+ channel of muscle cells also blocks to almost 100 per cent the PHA-induced activation of HPBL. This inhibition can be demonstrated regardless of whether the blocker is added together with or up to 4 h after PHA. As opposed to nifedipine charybdotoxin shows no effect if added 18 h after the initiation of the activation process. When nifedipine and charybdotoxin were tested on mice splenocytes we found that nifedipine fully inhibits the LPS-promoted activation of these cells while charybdotoxin has no effect on their activation.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Charybdotoxin-sensitive, Ca(2+)-dependent membrane potential changes are not involved in human T or B cell activation and proliferation.J Immunol. 1991 Nov 15;147(10):3452-8. J Immunol. 1991. PMID: 1719077
-
WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.Mol Pharmacol. 1995 Jul;48(1):98-104. Mol Pharmacol. 1995. PMID: 7542739
-
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.Proc Natl Acad Sci U S A. 1989 Dec;86(24):10171-5. doi: 10.1073/pnas.86.24.10171. Proc Natl Acad Sci U S A. 1989. PMID: 2481312 Free PMC article.
-
The interference of T cell activation by calcium channel blocking agents.J Immunol. 1984 Dec;133(6):2904-9. J Immunol. 1984. PMID: 6092460
-
T cell activation is regulated by voltage-dependent and calcium-activated potassium channels.J Immunol. 1996 Feb 15;156(4):1425-30. J Immunol. 1996. PMID: 8568243
Cited by
-
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin.Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10094-8. doi: 10.1073/pnas.89.21.10094. Proc Natl Acad Sci U S A. 1992. PMID: 1279670 Free PMC article.
-
Use of toxins to study potassium channels.J Bioenerg Biomembr. 1991 Aug;23(4):615-46. doi: 10.1007/BF00785814. J Bioenerg Biomembr. 1991. PMID: 1917911 Review.
-
Assembly and suppression of endogenous Kv1.3 channels in human T cells.J Gen Physiol. 1996 Mar;107(3):409-20. doi: 10.1085/jgp.107.3.409. J Gen Physiol. 1996. PMID: 8868051 Free PMC article.
-
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.J Exp Med. 1993 Mar 1;177(3):637-45. doi: 10.1084/jem.177.3.637. J Exp Med. 1993. PMID: 7679705 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials